Home/Filings/4/A/0001209191-19-019066
4/A//SEC Filing

Kendall David M 4/A

Accession 0001209191-19-019066

CIK 0000899460other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 12:20 PM ET

Size

4.6 KB

Accession

0001209191-19-019066

Insider Transaction Report

Form 4/AAmended
Period: 2018-11-14
Kendall David M
Chief Medical Officer
Transactions
  • Purchase

    Common Stock, $0.01 Par Value

    2018-11-14$1.77/sh+2,824$4,9982,824 total

Issuer

MANNKIND CORP

CIK 0000899460

Entity typeother

Related Parties

1
  • filerCIK 0001732647

Filing Metadata

Form type
4/A
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 12:20 PM ET
Size
4.6 KB